RZLT Rezolute, Inc. - Common Stock (NV)
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Eyl 24, 2026
$4,01
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,0752 haftanın en düşüğü
$11,4652 haftanın en yükseği
Piyasa Değeri (MRQ)
$387M
P/E
-5.3
Hisse Başına Kâr
$-0.75
rozetleriniz
52 Haftlık Aralık
$1–$11
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$9
P/E
-5.3
ROE
-67.8%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
RZLT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$4.01
Piyasa Değeri (MRQ)
$387M
P/E
-5.3
Hisse Başına Kâr
$-0.75
ROE
-67.8%
52 Haftlık Aralık
$1–$11
RZLT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 13 Ekim 2020 | 1-for-50 | Ters |
| 01 Mayıs 2014 | 1-for-6 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-0.752021-06-30 → 2026-06-30
Serbest Nakit Akışı·2019-06-30 → 2023-06-30
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | RZLT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -5.35Y ort. ≈-3.6 | ≈-3.6 | · | · | |
| F/D (MRQ) | 3.85Y ort. ≈2.1 | ≈2.1 | 2.7 | Aşırı değerli | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -6.05Y ort. ≈-4.3 | ≈-4.3 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 3.85Y ort. ≈2.1 | ≈2.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | RZLT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -53.8%5Y ort. ≈-47.0% | ≈-47.0% | -53.9% | Aynı seviyede | |
| ROE | -67.8%5Y ort. ≈-55.9% | ≈-55.9% | -72.6% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | RZLT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 9.75Y ort. ≈23.9 | ≈23.9 | 5.9 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 9.45Y ort. ≈23.5 | ≈23.5 | 5.8 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-9.8%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 31 Aralık 2026 | $-0.20 | $-0.15 | -32.5% | |
| 30 Haziran 2026 | $-0.20 | $-0.15 | -32.5% | |
| 31 Mart 2026 | $-0.16 | $-0.18 | 12.3% | |
| 31 Aralık 2025 | $-0.22 | $-0.19 | -15.4% | |
| 30 Eylül 2025 | $-0.18 | $-0.27 | 33.4% | |
| 30 Haziran 2025 | $-0.26 | $-0.22 | -15.9% | |
| 31 Mart 2025 | $-0.27 | $-0.23 | -18.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $54M | $62M | $56M | $44M | $32M | $15M | $14M | $19M | $17M | $12M | $9M | $5M | |
| SG&A Expense | $29M | $18M | $15M | $12M | $9M | $8M | $6M | $7M | $9M | $8M | $6M | $6M | |
| Operating Expenses | $83M | $80M | $70M | $56M | $42M | $23M | $21M | $26M | $29M | $20M | $15M | $11M | |
| Operating Income | $-83M | $-80M | $-70M | $-56M | $-42M | $-23M | $-21M | $-26M | $-29M | $-20M | $-15M | $-11M | |
| Interest Expense | · | · | · | · | · | $375.0K | $0 | $5M | $689.0K | $1.6K | $5.0K | $6.7K | |
| Interest Income | · | · | · | · | · | · | · | · | $1.0K | $0 | $965 | $5.0K | |
| Other Non-op | · | $5M | $2M | $4M | $783.0K | $2M | $188.0K | $-5M | $-1M | $46.9K | $15.7K | $-664.5K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-78M | $-74M | $-68M | $-52M | $-41M | $-21M | $-20M | $-30M | $-30M | $-20M | $-15M | $-11M | |
| EPS (Basic) | $-0.75 | $-0.98 | $-1.33 | $-1.01 | $-2.26 | $-2.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.75 | $-0.98 | $-1.33 | $-1.01 | $-2.32 | $-2.72 | · | · | · | · | · | · | |
| Shares (Basic) | 103,907,114 | 75,999,290 | 51,466,150 | 51,187,000 | 18,197,000 | 7,671,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 103,907,114 | 75,999,290 | 51,466,150 | 51,187,000 | 19,487,000 | 7,671,000 | · | · | · | · | · | · | |
| EBITDA | $-83M | $-80M | $-70M | $-56M | $-42M | · | $-21M | $-26M | · | $-20M | $-15M | $-11M |
Bilanço
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $94M | $70M | $16M | $150M | $41M | $77M | $38M | $2M | $4M | $4M | $5M | |
| Short-term Investments | $97M | $74M | $56M | $86M | · | · | · | · | · | · | · | · | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $67.2K | |
| Prepaid Expense | $3M | $3M | $2M | $3M | $2M | $946.0K | $563.0K | $571.0K | $362.0K | · | · | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | $361.9K | $442.0K | $430.1K | $387.5K | |
| Current Assets | $111M | $171M | $129M | $105M | $152M | $42M | $11M | $12M | $2M | $5M | $4M | $6M | |
| PP&E (Net) | $41.0K | $72.0K | $103.0K | $139.0K | $16.0K | $29.0K | $33.0K | $44.0K | $368.0K | $5M | $6M | $5M | |
| PP&E (Gross) | $210.0K | $210.0K | $210.0K | $210.0K | $56.0K | $56.0K | $47.0K | $47.0K | $886.0K | $7M | $7M | $5M | |
| Accum. Depreciation | $169.0K | $138.0K | $107.0K | $71.0K | $40.0K | $27.0K | $14.0K | $3.0K | $518.0K | $2M | $879.2K | $136.6K | |
| Intangibles | · | · | · | · | · | · | $0 | $29.0K | $37.0K | $44.3K | $51.6K | $58.9K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Total Assets | $113M | $175M | $133M | $124M | $152M | $43M | $11M | $12M | $3M | $11M | $11M | $11M | |
| Accounts Payable | $5M | $6M | $5M | $3M | $1M | $1M | $893.0K | $563.0K | $2M | $951.2K | $2M | $1M | |
| Current Liabilities | $11M | $12M | $10M | $5M | $2M | $2M | $3M | $8M | $6M | $2M | $2M | $2M | |
| Capital Leases | $276.0K | $983.0K | $2M | $2M | $80.0K | $187.0K | $165.0K | $0 | · | · | $0 | $23.1K | |
| Other Non-current Liabilities | · | · | · | · | · | · | $0 | $121.0K | $216.0K | $304.6K | $400.0K | $480.5K | |
| Total Liabilities | $12M | $13M | $12M | $8M | $3M | $17M | $4M | $10M | $6M | $2M | $2M | $2M | |
| Long-term Debt | · | · | · | · | · | $14M | $0 | $0 | $3M | · | · | · | |
| Common Stock | $96.0K | $87.0K | $53.0K | $37.0K | $34.0K | $8.0K | $6.0K | $4.0K | $62.0K | $49.2K | $35.1K | $24.3K | |
| Paid-in Capital | $582M | $566M | $450M | $377M | $359M | $194M | $155M | $129M | $90M | $73M | $53M | $38M | |
| Retained Earnings | $-481M | $-404M | $-329M | $-261M | $-209M | $-168M | $-147M | $-127M | $-94M | $-64M | $-44M | $-29M | |
| AOCI | $-119.0K | $-7.0K | $-79.0K | $-351.0K | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $101M | $162M | $121M | $116M | $149M | $26M | $7M | $2M | $-4M | $9M | $9M | $9M | |
| Liabilities + Equity | $113M | $175M | $133M | $124M | $152M | $43M | $11M | $12M | $3M | $11M | $11M | $11M | |
| Shares Outstanding | 96,405,982 | 86,995,985 | 53,245,824 | 36,827,000 | 33,582,000 | 8,352,000 | 5,867,000 | 4,208,000 | 62,166 | 49,228,640 | 35,110,916 | 24,338,219 |
Nakit Akışı
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31.0K | $31.0K | $36.0K | $30.0K | $13.0K | $13.0K | $18.0K | $49.0K | $1M | · | · | · | |
| Stock-based Comp | $14M | $7M | $7M | $7M | $4M | $4M | $3M | $3M | $5M | $6M | $4M | $3M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | · | · | · | · | $7.0K | $7.0K | $7.0K | $7.3K | $7.3K | $5.3K | |
| Restructuring | · | · | · | · | · | $201.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-65M | $-69M | $-57M | $-44M | $-40M | $-20M | $-24M | $-15M | $-14M | $-13M | $-10M | $-7M | |
| CapEx | · | · | · | $153.0K | · | · | $0 | $47.0K | $6.0K | · | · | · | |
| Investing Cash Flow | $-21M | $-15M | $49M | $-101M | · | $0 | $0 | $231.0K | $2M | $-195.4K | · | · | |
| Stock Issued | · | · | · | · | · | $0 | $24M | $0 | $4M | · | · | · | |
| Stock Repurchased | · | · | $3.0K | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $-3.0K | · | · | · | $24M | $0 | · | · | · | · | |
| Financing Cash Flow | $2M | $107M | $63M | $12M | $149M | $52M | $23M | $25M | $10M | $14M | · | · | |
| Net Change in Cash | $-83M | $24M | $54M | $-134M | $109M | $31M | $-2M | $10M | · | · | · | · | |
| Free Cash Flow | · | · | · | $-45M | · | · | $-24M | $-15M | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -53.8% | -48.3% | -53.4% | -37.5% | -42.1% | · | -175.2% | -412.7% | · | -188.3% | -134.8% | -121.7% | |
| ROE | -67.8% | -56.9% | -71.4% | -42.5% | -40.8% | · | -229.9% | -951.1% | · | -234.4% | -167.6% | -147.0% |
Likidite ve Solventlik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | 14.4 | 13.4 | 20.2 | 61.8 | · | 3.3 | 1.4 | · | 2.8 | 2.6 | 3.6 | |
| Quick Ratio | 9.4 | 14.1 | 13.2 | 19.6 | 61.1 | · | 3.1 | 1.4 | · | 2.5 | 2.3 | 3.1 | |
| Interest Coverage | · | · | · | · | · | · | · | -5.2 | · | -12742.3 | -2967.1 | -1589.8 |
Hisse Başına
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.04 | $1.86 | $2.27 | $3.15 | $4.45 | · | $1.26 | $8.33 | · | $0.17 | $0.25 | $0.37 | |
| Cash Flow / Share | $-0.62 | $-0.91 | $-1.11 | $-0.87 | $-2.03 | · | · | · | · | · | · | · | |
| Cash / Share | $0.11 | $1.08 | $1.32 | $0.44 | $4.48 | · | $1.70 | $55.01 | · | $0.09 | $0.12 | $0.22 | |
| EPS (TTM) | $-0.75 | $-0.98 | $-1.33 | $-1.01 | $-2.32 | $-2.72 | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-78M | $-74M | $-68M | $-52M | $-41M | $-21M | $-20M | $-30M | $-30M | $-20M | $-15M | $-11M | |
| Market Cap | $501M | $388M | $229M | $73M | $108M | · | $27M | $2M | · | $2.78B | $1.76B | $2.37B | |
| P/E | -6.9 | -4.6 | -3.2 | -2.0 | -1.4 | -5.2 | · | · | · | · | · | · | |
| P/B | 5.0 | 2.4 | 1.9 | 0.6 | 0.7 | · | 3.7 | 1.2 | · | 326.2 | 200.1 | 262.1 | |
| P / Tangible Book | 5.0 | 2.4 | 1.9 | 0.6 | 0.7 | 4.6 | 3.7 | · | · | · | · | · | |
| P / Cash Flow | -7.8 | -5.6 | -4.0 | -1.6 | -2.7 | · | -1.1 | -0.1 | · | -208.9 | -167.4 | -335.2 | |
| P / FCF | · | · | · | -1.6 | · | · | -1.1 | -0.1 | · | · | · | · | |
| Earnings Yield | -14.4% | -22.0% | -30.9% | -51.0% | -71.8% | -19.1% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $11M | $14M | $13M | $21M | $15M | $13M | $13M | $19M | $12M | $12M | $12M | $11M | $14M | $11M | $8M | |
| SG&A Expense | $7M | $6M | $10M | $7M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $22M | $17M | $24M | $20M | $26M | $20M | $17M | $17M | $23M | $16M | $15M | $16M | $14M | $17M | $14M | $10M | |
| Operating Income | $-22M | $-17M | $-24M | $-20M | $-26M | $-20M | $-17M | $-17M | $-23M | $-16M | $-15M | $-16M | $-14M | $-17M | $-14M | $-10M | |
| Other Non-op | · | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $126.0K | $-837.0K | $1M | $1M | $2M | $1M | $836.0K | $387.0K | |
| Net Income | $-20M | $-16M | $-23M | $-18M | $-24M | $-19M | $-16M | $-15M | $-23M | $-17M | $-14M | $-15M | $-13M | $-16M | $-14M | $-10M | |
| EPS (Basic) | $-0.19 | $-0.16 | $-0.22 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.22 | $-0.44 | $-0.34 | $-0.27 | $-0.28 | $-0.26 | $-0.30 | $-0.26 | $-0.19 | |
| EPS (Diluted) | $-0.19 | $-0.16 | $-0.22 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.22 | $-0.44 | $-0.34 | $-0.27 | $-0.28 | $-0.26 | $-0.30 | $-0.26 | $-0.19 | |
| Shares (Basic) | · | 104,040,292 | 103,687,064 | 103,422,647 | · | 70,031,041 | 69,940,319 | 69,736,150 | · | 50,812,332 | 51,408,000 | 51,409,000 | · | 51,409,000 | 51,410,000 | 50,528,000 | |
| Shares (Diluted) | · | 104,040,292 | 103,687,064 | 103,422,647 | · | 70,031,041 | 69,940,319 | 69,736,150 | · | 50,812,332 | 51,408,000 | 51,409,000 | · | 51,409,000 | 51,410,000 | 50,528,000 | |
| EBITDA | · | · | $-24M | $-20M | · | $-20M | $-17M | $-17M | · | $-16M | $-15M | $-16M | · | $-17M | $-14M | $-10M |
Bilanço
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $11M | $12M | $9M | $94M | $15M | $9M | $10M | $70M | $6M | $13M | $8M | $16M | $34M | $147M | $154M | |
| Short-term Investments | $97M | $109M | $121M | $143M | $74M | $72M | $88M | $98M | $56M | $74M | $80M | $91M | $86M | $69M | · | · | |
| Prepaid Expense | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $3M | $2M | $860.0K | $1M | |
| Current Assets | $111M | $122M | $135M | $155M | $171M | $89M | $99M | $110M | $129M | $82M | $96M | $103M | $105M | $106M | $148M | $156M | |
| PP&E (Net) | $41.0K | $49.0K | $57.0K | $64.0K | $72.0K | $80.0K | $87.0K | $95.0K | $103.0K | $110.0K | $119.0K | $129.0K | $139.0K | $149.0K | $160.0K | $83.0K | |
| PP&E (Gross) | $210.0K | · | · | · | $210.0K | · | · | · | $210.0K | · | · | · | $210.0K | · | · | · | |
| Accum. Depreciation | $169.0K | · | · | · | $138.0K | · | · | · | $107.0K | · | · | · | $71.0K | · | · | · | |
| Total Assets | $113M | $125M | $139M | $159M | $175M | $95M | $112M | $123M | $133M | $88M | $102M | $113M | $124M | $134M | $150M | $156M | |
| Accounts Payable | $5M | $3M | $4M | $3M | $6M | $7M | $3M | $2M | $5M | $3M | $4M | $2M | $3M | $3M | $3M | $1M | |
| Current Liabilities | $11M | $8M | $10M | $10M | $12M | $11M | $11M | $8M | $10M | $7M | $8M | $7M | $5M | $4M | $6M | $2M | |
| Capital Leases | $276.0K | $438.0K | $619.0K | $804.0K | $983.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $49.0K | |
| Total Liabilities | $12M | $9M | $11M | $11M | $13M | $12M | $12M | $10M | $12M | $17M | $10M | $9M | $8M | $7M | $9M | $3M | |
| Common Stock | $96.0K | $96.0K | $96.0K | $91.0K | $87.0K | $61.0K | $61.0K | $55.0K | $53.0K | $40.0K | $40.0K | $37.0K | $37.0K | $37.0K | $37.0K | $37.0K | |
| Paid-in Capital | $582M | $578M | $573M | $569M | $566M | $462M | $460M | $458M | $450M | $377M | $381M | $379M | $377M | $376M | $374M | $372M | |
| Retained Earnings | $-481M | $-461M | $-445M | $-422M | $-404M | $-379M | $-361M | $-345M | $-329M | $-306M | $-289M | $-276M | $-261M | $-248M | $-233M | $-219M | |
| AOCI | $-119.0K | $-115.0K | $47.0K | $49.0K | $-7.0K | $43.0K | $64.0K | $289.0K | $-79.0K | $-78.0K | $-48.0K | $-284.0K | $-351.0K | $-132.0K | · | · | |
| Stockholders' Equity | $101M | $117M | $128M | $147M | $162M | $83M | $100M | $113M | $121M | $71M | $92M | $104M | $116M | $127M | $141M | $153M | |
| Liabilities + Equity | $113M | $125M | $139M | $159M | $175M | $95M | $112M | $123M | $133M | $88M | $102M | $113M | $124M | $134M | $150M | $156M | |
| Shares Outstanding | 96,405,982 | 96,292,331 | 95,547,998 | 91,036,700 | 86,995,985 | 60,542,914 | 60,535,000 | 55,394,000 | 53,245,824 | 40,132,000 | 39,625,000 | 36,827,000 | 36,827,000 | 36,827,000 | 36,827,000 | 36,827,000 |
Nakit Akışı
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.0K | $8.0K | $7.0K | $8.0K | $8.0K | $7.0K | $8.0K | $8.0K | $7.0K | $9.0K | $10.0K | $10.0K | $9.0K | $11.0K | $7.0K | $3.0K | |
| Stock-based Comp | $4M | $4M | $3M | $3M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-13M | $-14M | $-20M | $-17M | $-22M | $-17M | $-14M | $-16M | $-19M | $-15M | $-13M | $-11M | $-11M | $-18M | $-7M | $-8M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $83.0K | $70.0K | |
| Investing Cash Flow | $12M | $12M | $23M | $-68M | $346.0K | $23M | $11M | $-49M | $20M | $9M | $18M | $3M | $-6M | $-95M | $-83.0K | $-70.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | · | · | |
| Financing Cash Flow | $227.0K | $747.0K | $356.0K | $911.0K | $101M | $10.0K | $657.0K | $6M | $63M | $-3.0K | · | · | $0 | $0 | $0 | $12M | |
| Net Change in Cash | $-621.0K | $-708.0K | $3M | $-85M | $80M | $6M | $-2M | $-60M | $64M | $-7M | $4M | $-8M | $-18M | $-113M | $-8M | $4M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-8M |
Kârlılık
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | · | -18.2% | -12.9% | · | -20.7% | -14.7% | -13.0% | · | -15.4% | -11.0% | -10.8% | · | -15.4% | -11.6% | -10.1% | |
| ROE | · | · | -20.0% | -13.9% | · | -24.6% | -16.4% | -14.2% | · | -17.2% | -11.9% | -11.3% | · | -17.5% | -13.3% | -11.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 14.2 | 15.2 | · | 8.4 | 9.3 | 13.8 | · | 11.8 | 12.0 | 14.3 | · | 24.1 | 23.4 | 64.1 | |
| Quick Ratio | · | · | 14.0 | 14.9 | · | 8.3 | 9.1 | 13.5 | · | 11.5 | 11.6 | 13.7 | · | 23.5 | 23.2 | 63.5 |
Hisse Başına
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $1.34 | $1.62 | · | $1.36 | $1.65 | $2.05 | · | $1.77 | $2.31 | $2.81 | · | $3.46 | $3.84 | $4.16 | |
| Cash Flow / Share | · | · | · | $-0.17 | · | · | · | $-0.23 | · | · | · | $-0.21 | · | · | · | $-0.15 | |
| Cash / Share | · | · | $0.12 | $0.10 | · | $0.24 | $0.15 | $0.19 | · | $0.15 | $0.32 | $0.22 | · | $0.92 | $3.98 | $4.19 | |
| EPS (TTM) | · | $-0.83 | $-0.94 | $-0.94 | · | $-1.15 | $-1.22 | $-1.27 | · | $-1.15 | $-1.11 | $-1.10 | · | $-0.70 | $-1.05 | $-1.59 |
Değerleme (TTM)
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | · | $-81M | $-84M | $-77M | · | $-73M | $-71M | $-69M | · | $-58M | $-57M | $-56M | · | $-48M | $-44M | $-43M | |
| Market Cap | · | · | $225M | $856M | · | $176M | $297M | $269M | · | $102M | $39M | $49M | · | $71M | $76M | $101M | |
| P/E | · | -3.7 | -2.5 | -10.0 | · | -2.5 | -4.0 | -3.8 | · | -2.2 | -0.9 | -1.2 | · | -2.7 | -2.0 | -1.7 | |
| P/B | · | · | 1.8 | 5.8 | · | 2.1 | 3.0 | 2.4 | · | 1.4 | 0.4 | 0.5 | · | 0.6 | 0.5 | 0.7 | |
| P / Tangible Book | · | 2.5 | 1.8 | 5.8 | · | 2.1 | 3.0 | 2.4 | · | 1.4 | 0.4 | 0.5 | · | 0.6 | 0.5 | 0.7 | |
| P / Cash Flow | · | · | · | -49.1 | · | · | · | -16.8 | · | · | · | -4.6 | · | · | · | -13.3 | |
| Earnings Yield | · | -27.2% | -39.8% | -10.0% | · | -39.7% | -24.9% | -26.2% | · | -45.1% | -111.8% | -83.3% | · | -36.5% | -50.7% | -58.0% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Net Gelir | $-78M | $-74M | $-68M | $-52M | $-41M |
| Seyreltilmiş Hisse Başı Kâr | $-0.75 | $-0.98 | $-1.33 | $-1.01 | $-2.32 |
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Cari Oran | 9.7 | 14.4 | 13.4 | 20.2 | 61.8 |
| Cari Oran | 9.4 | 14.1 | 13.2 | 19.6 | 61.1 |
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | · | · | $-45M | · |
Kurumsal Sahipler (13F) 154 dosya · $475.2M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
154
Tutulan Değer
$475.2M
Yeni pozisyonlar
41
Çıkan pozisyonlar
19
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 41 (+5 önceki Ç'ye göre) | 19 (-16 önceki Ç'ye göre) | 63 (+24 önceki Ç'ye göre) | 30 (-11 önceki Ç'ye göre) | +1.4M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FEDERATED HERMES, INC. | $67.551.427 | 12.990.659 | 14,22% | Hisse senetleri |
| RA CAPITAL MANAGEMENT, L.P. | $49.114.203 | 9.445.039 | 10,34% | Hisse senetleri |
| BlackRock, Inc. | $40.135.113 | 7.718.291 | 8,45% | Hisse senetleri |
| Opaleye Management Inc. | $32.760.000 | 6.300.000 | 6,89% | Hisse senetleri |
| Balyasny Asset Management L.P. | $24.242.603 | 4.662.039 | 5,10% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.946.300 | 3.835.827 | 4,20% | Hisse senetleri |
| Siren, L.L.C. | $17.307.092 | 3.328.287 | 3,64% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $13.320.601 | 2.561.654 | 2,80% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $12.788.402 | 2.459.308 | 2,69% | Hisse senetleri |
| VANGUARD GROUP INC | $11.300.886 | 4.788.511 | 2,38% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $11.288.227 | 2.170.154 | 2,38% | Hisse senetleri |
| STATE STREET CORP | $9.620.666 | 1.850.128 | 2,02% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $9.564.656 | 1.839.357 | 2,01% | Hisse senetleri |
| MORGAN STANLEY | $8.417.671 | 1.618.783 | 1,77% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.772.960 | 1.494.800 | 1,64% | Alım opsiyonu |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.179.879 | 1.380.746 | 1,51% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $6.847.267 | 1.316.782 | 1,44% | Hisse senetleri |
| Nuveen, LLC | $6.735.087 | 1.295.209 | 1,42% | Hisse senetleri |
| KENNEDY CAPITAL MANAGEMENT LLC | $6.352.726 | 1.221.678 | 1,34% | Hisse senetleri |
| Blackstone Inc. | $5.631.220 | 1.082.927 | 1,19% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $5.241.400 | 1.007.962 | 1,10% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $5.200.000 | 1.000.000 | 1,09% | Hisse senetleri |
| GREAT POINT PARTNERS LLC | $4.949.407 | 951.809 | 1,04% | Hisse senetleri |
| Ikarian Capital, LLC | $4.862.062 | 935.012 | 1,02% | Hisse senetleri |
| Squadron Capital Management LLC | $4.680.000 | 900.000 | 0,98% | Alım opsiyonu |
| DIMENSIONAL FUND ADVISORS LP | $4.631.598 | 890.733 | 0,97% | Hisse senetleri |
| 22NW, LP | $4.267.396 | 820.653 | 0,90% | Hisse senetleri |
| Velan Capital Investment Management LP | $3.900.000 | 750.000 | 0,82% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $3.797.726 | 730.332 | 0,80% | Hisse senetleri |
| NORTHERN TRUST CORP | $3.771.409 | 725.271 | 0,79% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.762.658 | 723.588 | 0,79% | Hisse senetleri |
| Woodline Partners LP | $3.181.344 | 611.797 | 0,67% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $2.969.392 | 571.037 | 0,62% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $2.689.617 | 517.234 | 0,57% | Hisse senetleri |
| J. Goldman & Co LP | $2.602.106 | 500.405 | 0,55% | Hisse senetleri |
| Integral Health Asset Management, LLC | $2.600.000 | 500.000 | 0,55% | Hisse senetleri |
| UBS Group AG | $2.579.371 | 496.033 | 0,54% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $2.241.580 | 431.073 | 0,47% | Hisse senetleri |
| Squadron Capital Management LLC | $2.097.732 | 403.410 | 0,44% | Hisse senetleri |
| Vestal Point Capital, LP | $1.991.595 | 382.999 | 0,42% | Hisse senetleri |
| Knott David M Jr | $1.924.000 | 370.000 | 0,40% | Hisse senetleri |
| XTX Topco Ltd | $1.839.084 | 353.670 | 0,39% | Hisse senetleri |
| Driehaus Capital Management LLC | $1.505.499 | 289.519 | 0,32% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.492.166 | 286.955 | 0,31% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $1.454.133 | 279.641 | 0,31% | Hisse senetleri |
| JANE STREET GROUP, LLC | $1.372.171 | 263.879 | 0,29% | Hisse senetleri |
| Schonfeld Strategic Advisors LLC | $1.371.478 | 263.746 | 0,29% | Hisse senetleri |
| Point72 Europe (London) LLP | $1.200.759 | 127.740 | 0,25% | Hisse senetleri |
| FMR LLC | $1.123.808 | 216.117 | 0,24% | Hisse senetleri |
| Bank of New York Mellon Corp | $1.103.804 | 212.270 | 0,23% | Hisse senetleri |
Aktivistler ve %5+ sahipler 13 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Genexine, Inc. ×2 başvurular | 03 Mayıs 2023 | · | İlk başvuru | · | SEC |
| Handok, Inc. | 31 Mart 2020 | · | İlk başvuru | · | SEC |
| Steve Howe | 24 Ocak 2014 | · | İlk başvuru | · | SEC |
| Theodore Kalem | 11 Şubat 2013 | · | İlk başvuru | Pasif yatırım | SEC |
| Konus Advisory Group, Inc., Hoyoung Huh, Nevan Elam | 08 Şubat 2013 | · | İlk başvuru | Pasif yatırım | SEC |
| Sankaram Mantripragada ×2 başvurular | 08 Şubat 2013 | · | İlk başvuru | Pasif yatırım | SEC |
| Nickolay Kukekov | 08 Şubat 2013 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi | 14 Eylül 2012 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 14 Eylül 2012 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 14 Eylül 2012 | · | İlk başvuru | · | SEC |
| Juemin Chu | 14 Şubat 2012 | · | İlk başvuru | Pasif yatırım | SEC |
| Orit Wolkin | 14 Şubat 2012 | · | İlk başvuru | Pasif yatırım | SEC |
| KAEYO Investments Ltd. | 14 Şubat 2012 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 25 içeriden öğrenenler · 10 yöneticiler · 14 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Nevan C Elam | CEO | 02 Temmuz 2026 F | 605.497 | 1 | 0 | $50.880 |
| Daron Evans | CFO | 02 Temmuz 2026 F | 411.400 | 4 | 0 | $108.225 |
| Keith A. Vendola | Chief Financial Officer | 31 Temmuz 2019 A | · | 0 | 0 | $0 |
| Nir Bar | President and Treasurer | 04 Eylül 2012 S | 0 | 0 | 0 | $0 |
| Sunil Ratilal Karnawat | Chief Commercial Officer | 02 Eylül 2026 F | 69.275 | 2 | 0 | $19.600 |
| Brian Kenneth Roberts | Chief Medical Officer | 02 Temmuz 2026 F | 293.851 | 1 | 0 | $47.600 |
| Sankaram Mantripragada | Chief Scientific Officer | 31 Temmuz 2019 A | · | 0 | 0 | $0 |
| Morgan Fields | Chief Accounting Officer | 31 Ekim 2016 A | · | 0 | 0 | $0 |
| Hoyoung Huh | Chairman, Scientific Adv. Bd. | 31 Ekim 2016 A | 5.057.693 | 0 | 0 | $0 |
| Guy Turnowski | Secretary | 04 Eylül 2012 S | 0 | 0 | 0 | $0 |
| Wladimir Hogenhuis | Yönetim kurulu üyesi | 16 Aralık 2025 P | 119.675 | 1 | 0 | $9.548 |
| Philippe Fauchet | Yönetim kurulu üyesi | 19 Kasım 2025 A | 55.500 | 0 | 0 | $0 |
| Erik Harris | Yönetim kurulu üyesi | 19 Kasım 2025 A | 21.000 | 0 | 0 | $0 |
| Young-Jin Kim | Yönetim kurulu üyesi | 19 Kasım 2025 A | 170.950 | 0 | 0 | $0 |
| Nerissa Kreher | Yönetim kurulu üyesi | 19 Kasım 2025 A | 58.576 | 0 | 0 | $0 |
| Gil M Labrucherie | Yönetim kurulu üyesi | 19 Kasım 2025 A | 55.500 | 0 | 0 | $0 |
| HANDOK, INC. | Yönetim kurulu üyesi | 22 Temmuz 2022 P | 5.942.617 | 0 | 0 | $0 |
| David F Welch | Yönetim kurulu üyesi | 10 Mart 2017 P | 1.811.415 | 0 | 0 | $0 |
| Barry Michael Sherman | Yönetim kurulu üyesi | 31 Ekim 2016 A | · | 0 | 0 | $0 |
| Steve Howe | Yönetim kurulu üyesi | 30 Nisan 2014 A | · | 0 | 0 | $0 |
| Genexine Inc. | 10% sahip | 26 Nisan 2019 C | 91.300.933 | 0 | 0 | $0 |
| Konus Advisory Group, Inc. | 10% sahip | 31 Mart 2014 J | 5.057.693 | 0 | 0 | $0 |
| Jue Min Chu | 10% sahip | 04 Eylül 2012 S | 0 | 0 | 0 | $0 |
| KAEYO INVESTMENTS LTD | 10% sahip | 04 Eylül 2012 S | 0 | 0 | 0 | $0 |
| Orit Wolkin | 10% sahip | 04 Eylül 2012 S | 0 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 22 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,79% | 77.705 NS | 31 Temmuz 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,42% | 320.855 NS | 31 Temmuz 2026 | N-PORT |
| IWC · iShares Trust | 0,08% | 264.133 SH | 11 Eylül 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,03% | 130.974 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 59.002 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 37.404 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 2.027.959 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.005.418 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 450.381 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,01% | 319.926 NS | 31 Temmuz 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 97.914 SH | 11 Eylül 2026 | Günlük |
| DFSU · Dimensional ETF Trust | 0,00% | 12.923 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 13.711 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 19.647 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 120.621 SH | 11 Eylül 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,00% | 50.203 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 6.281 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.744.647 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10.825 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.900 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,00% | 187.511 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 633.100 SH | 11 Eylül 2026 | Günlük |
RZLT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 16 analist
AL
Medyan hedef
$10.00
+149,4%
6 37,5%
Güçlü Al
7 43,8%
Al
3 18,8%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
9 analist · 2026-09-30Ortalama hedef $9.11 +127,2%
← Tüm hedeflerin altında
Mevcut fiyat $4.01
Düşük$6.00
Ortalama$9.11
Yüksek$14.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| RZLT | $501M | -6.9 | · | · | -67.8% | · |
| EIKN | · | · | · | · | · | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| GALT | $271M | -8.7 | · | · | 25.0% | · |
| KYTX | $568M | -2.6 | · | · | -77.4% | · |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | · |
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-K dosyalandı Eyl 24, 2026